drugset

drugset / Trial / NCT07498439

TILs Therapy for Multiple Primary Early-Stage NSCLC

NCT07498439 ↗

Phase 0 Not yet recruiting 50 enrolled Tianjin Medical University General Hospital

NaSingle-groupOpen-labelTreatment

Summary

This is a single-arm study aimed at evaluating the safety of TILs therapy for multiple primary early-stage NSCLC

Timeline

Start: 2026-03-31
Primary completion: 2028-03-31
Completion: 2030-03-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TILs injection	Cell therapy	—	Intravenous

Indications